Van Eck Associates Corp Abcam PLC Transaction History

Van Eck Associates Corp

  • $80.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$21.54 - $24.41 $1,227 - $1,391
57 Added 1.72%
3,377 $76,000
Q2 2023

Aug 03, 2023
SELL
$12.62 - $24.47 $832 - $1,615
-66 Reduced 1.95%
3,320 $81,000
Q1 2023

May 03, 2023
SELL
$12.98 - $17.1 $1,947 - $2,565
-150 Reduced 4.24%
3,386 $46,000
Q4 2022

Feb 08, 2023
BUY
$13.92 - $17.0 $14,407 - $17,595
1,035 Added 41.38%
3,536 $55,000
Q3 2022

Oct 27, 2022
BUY
$13.36 - $16.75 $33,413 - $41,891
2,501 New
2,501 $37,000

Others Institutions Holding ABCM

# of Institutions
4
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Abcam plc

ABCM Quotes by TradingView
  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email